Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2004

View Archived Issues

Eisai inlicenses clevudine from Bukwang Pharm

Chiron will not file BLA for Menjugate meningococcal C vaccine

MMV and GlaxoSmithKline to develop GW-844520X for malaria

Rigel and Merck & Co. partner on ubiquitin ligases research for cancer

Namenda sNDA for mild Alzheimer's disease accepted for review

AEOL-10150 enters phase I in ALS

Enrollment closes in Chinese Femprox study

Glufosfamide receives fast track status for pancreatic cancer

TPI-926 enters phase II for CNS disorder

TS-2037 demonstrates potent activity against MRSA

Novel lantibiotic has potent antimicrobial activity

Molecular cloaking technology enhances development of HIV-1 entry inhibitors

Novel von Willebrand factor antagonist prevents occlusive thrombus formation in vivo

Dimiracetam derivative for the treatment of neuropathic pain

Antiinflammatory compound for the treatment of acute ischemic stroke

Thyroid hormone binding protein may provide protection against Alzheimer's disease

New histone deacetylase inhibitors in early development at Syrrx

CCR2 receptor modulators described by Merck

Merck patent claims bradykinin B1 receptor antagonist

Three series of CGRP receptor antagonists claimed by Merck

A series of fused pyrrole compounds described in a patent

Activity of and resistance to antimalarial ferroquine evaluated

K-777 active against Cryptosporidium parvum in vitro and in vivo

Good safety profile found for HyCAMP in colorectal cancer

GW-501516 increases HDL-cholesterol levels in healthy volunteers

Six-year benefits of lopinavir/ritonavir therapy in HIV-infected patients

Uptake of DB-75 in Trypanosoma brucei brucei elucidated

Phase I/II data on the safety of PKC-412 plus imatinib mesylate in GIST

Antirestenotic activity of MS-275 measured in vitro, in vivo

Hemodynamic, renal effects of tolvaptan studied in congestive heart failure model

Antiatherosclerotic activity of S-1627 revealed in two species

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...